BSGM: Biosig Technologies Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Biosig Technologies Inc (BSGM).
$25.68M Market Cap.
BSGM Market Cap. (MRY)
BSGM Shares Outstanding (MRY)
BSGM Assets (MRY)
Total Assets
$842.00K
Total Liabilities
$2.26M
Total Investments
$17.00K
BSGM Income (MRY)
Revenue
$40.00K
Net Income
-$10.33M
Operating Expense
$12.90M
BSGM Cash Flow (MRY)
CF Operations
-$4.76M
CF Investing
$0
CF Financing
$4.71M
BSGM Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $842,000 (-53.17%) | $1,798,000 (-56.25%) | $4,110,000 (-73.52%) | $15,519,000 (-48.93%) |
Assets Current | $344,000 (-34.85%) | $528,000 (-53.19%) | $1,128,000 (-91.88%) | $13,894,000 (-52.64%) |
Assets Non-Current | $498,000 (-60.79%) | $1,270,000 (-57.41%) | $2,982,000 (83.51%) | $1,625,000 (54.91%) |
Goodwill & Intangible Assets | $269,000 (-6.60%) | $288,000 (-6.19%) | $307,000 (-5.83%) | $326,000 (-6.05%) |
Shareholders Equity | -$1,544,000 (48.84%) | -$3,018,000 (-1064.22%) | $313,000 (-97.44%) | $12,241,000 (-49.77%) |
Property Plant & Equipment Net | $181,000 (-80.35%) | $921,000 (-32.77%) | $1,370,000 (9.08%) | $1,256,000 (111.09%) |
Cash & Equivalents | $142,000 (-25.26%) | $190,000 (-46.78%) | $357,000 (-96.94%) | $11,659,000 (-58.90%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $5,000 (-86.49%) | $37,000 (0%) |
Total Investments | $17,000 (-85.83%) | $120,000 (-45.70%) | $221,000 (0%) | $0 (0%) |
Investments Current | $13,000 (-87.38%) | $103,000 (1.98%) | $101,000 (0%) | $0 (0%) |
Investments Non-Current | $4,000 (-76.47%) | $17,000 (-85.83%) | $120,000 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $1,477,000 (-21.48%) | $1,881,000 (144.92%) |
Trade & Non-Trade Receivables | $109,000 (354.17%) | $24,000 (166.67%) | $9,000 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,052,000 (-50.15%) | $4,116,000 (44.32%) | $2,852,000 (30.89%) | $2,179,000 (-53.85%) |
Accumulated Retained Earnings (Deficit) | -$255,345,000 (-4.22%) | -$245,015,000 (-13.45%) | -$215,974,000 (-14.32%) | -$188,922,000 (-20.33%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $102,000 (-77.43%) | $452,000 (-40.92%) | $765,000 (16.62%) | $656,000 (108.92%) |
Debt Current | $102,000 (-70.77%) | $349,000 (11.50%) | $313,000 (10.60%) | $283,000 (-9.58%) |
Debt Non-Current | $0 (0%) | $103,000 (-77.21%) | $452,000 (21.18%) | $373,000 (37200.00%) |
Total Liabilities | $2,264,000 (-51.68%) | $4,685,000 (26.18%) | $3,713,000 (25.69%) | $2,954,000 (-42.18%) |
Liabilities Current | $2,264,000 (-50.59%) | $4,582,000 (40.51%) | $3,261,000 (26.59%) | $2,576,000 (-49.57%) |
Liabilities Non-Current | $0 (0%) | $103,000 (-77.21%) | $452,000 (19.58%) | $378,000 (37700.00%) |
BSGM Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $40,000 (122.22%) | $18,000 (-93.71%) | $286,000 (-35.15%) | $441,000 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $57,000 (-71.36%) | $199,000 (0%) |
Selling General & Administrative Expense | $11,629,000 (-49.61%) | $23,077,000 (7.94%) | $21,380,000 (-23.24%) | $27,853,000 (-31.99%) |
Research & Development Expense | $832,000 (-83.66%) | $5,092,000 (-12.52%) | $5,821,000 (3.91%) | $5,602,000 (-69.11%) |
Operating Expenses | $12,902,000 (-54.78%) | $28,530,000 (3.77%) | $27,494,000 (-18.30%) | $33,653,000 (-43.14%) |
Interest Expense | $11,000 (222.22%) | -$9,000 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$10,339,000 (63.96%) | -$28,690,000 (-5.24%) | -$27,262,000 (17.03%) | -$32,856,000 (44.44%) |
Net Income to Non-Controlling Interests | -$9,000 (-102.56%) | $351,000 (267.14%) | -$210,000 (77.64%) | -$939,000 (86.43%) |
Net Income | -$10,330,000 (64.43%) | -$29,041,000 (-7.35%) | -$27,052,000 (15.24%) | -$31,917,000 (38.88%) |
Preferred Dividends Income Statement Impact | $183,000 (1933.33%) | $9,000 (-95.89%) | $219,000 (2333.33%) | $9,000 (-35.71%) |
Net Income Common Stock | -$10,513,000 (63.81%) | -$29,050,000 (-6.52%) | -$27,271,000 (14.58%) | -$31,926,000 (38.88%) |
Weighted Average Shares | $14,041,748 (91.00%) | $7,351,794 (70.68%) | $4,307,244 (28.53%) | $3,351,194 (20.09%) |
Weighted Average Shares Diluted | $14,041,748 (91.00%) | $7,351,794 (70.68%) | $4,307,244 (28.53%) | $3,351,194 (20.09%) |
Earning Before Interest & Taxes (EBIT) | -$10,319,000 (64.48%) | -$29,050,000 (-7.39%) | -$27,052,000 (15.24%) | -$31,917,000 (38.88%) |
Gross Profit | $40,000 (122.22%) | $18,000 (-92.14%) | $229,000 (-5.37%) | $242,000 (0%) |
Operating Income | -$12,862,000 (54.89%) | -$28,512,000 (-4.57%) | -$27,265,000 (18.40%) | -$33,411,000 (43.55%) |
BSGM Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$186,000 (-10.71%) | -$168,000 (69.00%) | -$542,000 (-522.99%) |
Net Cash Flow from Financing | $4,710,000 (-72.82%) | $17,332,000 (63.96%) | $10,571,000 (2.31%) | $10,332,000 (-75.89%) |
Net Cash Flow from Operations | -$4,758,000 (72.52%) | -$17,313,000 (20.23%) | -$21,705,000 (17.78%) | -$26,399,000 (0.76%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$48,000 (71.26%) | -$167,000 (98.52%) | -$11,302,000 (31.95%) | -$16,609,000 (-202.78%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | -$186,000 (-10.71%) | -$168,000 (69.00%) | -$542,000 (-522.99%) |
Issuance (Repayment) of Debt Securities | $500,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $4,210,000 (-72.59%) | $15,361,000 (45.31%) | $10,571,000 (2.31%) | $10,332,000 (-67.97%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $6,957,000 (-12.80%) | $7,978,000 (80.21%) | $4,427,000 (-54.92%) | $9,821,000 (-60.97%) |
Depreciation Amortization & Accretion | $504,000 (-22.94%) | $654,000 (-1.80%) | $666,000 (4.23%) | $639,000 (16.18%) |
BSGM Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (24.84%) | 80.10% (45.90%) | 54.90% |
Profit Margin | -26282.50% (83.71%) | -161388.90% (-1592.54%) | -9535.30% (-31.71%) | -7239.50% |
EBITDA Margin | -24537.50% (84.45%) | -157755.60% (-1609.92%) | -9225.90% (-30.08%) | -7092.50% |
Return on Average Equity (ROAE) | 670.00% (-88.70%) | 5928.60% (1099.26%) | -593.30% (-199.19%) | -198.30% (3.78%) |
Return on Average Assets (ROAA) | -604.50% (26.14%) | -818.40% (-134.50%) | -349.00% (-117.85%) | -160.20% (5.71%) |
Return on Sales (ROS) | -25797.50% (84.02%) | -161388.90% (-1606.25%) | -9458.70% (-30.69%) | -7237.40% |
Return on Invested Capital (ROIC) | 503.20% (-88.83%) | 4503.90% (419.88%) | -1408.00% (94.17%) | -24133.80% (-419.91%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.99 (-65.17%) | -1.2 (-81.17%) | -0.66 (71.71%) | -2.35 (-12.51%) |
Price to Sales Ratio (P/S) | 523.05 (-73.04%) | 1,940.06 (2967.14%) | 63.25 (-62.67%) | 169.46 |
Price to Book Ratio (P/B) | -16.63 (-19.94%) | -13.87 (-121.52%) | 64.44 (901.65%) | 6.43 (32.89%) |
Debt to Equity Ratio (D/E) | -1.47 (5.54%) | -1.55 (-113.08%) | 11.86 (4822.41%) | 0.24 (14.76%) |
Earnings Per Share (EPS) | -0.75 (81.01%) | -3.95 (37.60%) | -6.33 (33.37%) | -9.5 (49.20%) |
Sales Per Share (SPS) | 0 (50.00%) | 0 (-96.97%) | 0.07 (-50.00%) | 0.13 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.34 (85.76%) | -2.38 (53.13%) | -5.08 (36.83%) | -8.04 (15.94%) |
Book Value Per Share (BVPS) | -0.11 (73.24%) | -0.41 (-663.01%) | 0.07 (-98.00%) | 3.65 (-58.17%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.04 (-80.00%) | 0.2 (-76.78%) | 0.88 (-80.52%) | 4.53 (-57.88%) |
Enterprise Value Over EBIT (EV/EBIT) | -2 (-100.00%) | -1 (0.00%) | -1 (50.00%) | -2 (0.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.57 (-73.70%) | -1.48 (-93.59%) | -0.76 (61.36%) | -1.98 (-12.84%) |
Asset Turnover | 0.02 (360.00%) | 0.01 (-86.49%) | 0.04 (68.18%) | 0.02 (0%) |
Current Ratio | 0.15 (32.17%) | 0.12 (-66.76%) | 0.35 (-93.59%) | 5.39 (-6.08%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$4,758,000 (72.81%) | -$17,499,000 (20.00%) | -$21,873,000 (18.81%) | -$26,941,000 (-0.95%) |
Enterprise Value (EV) | $25,210,044 (-39.97%) | $41,994,093 (108.27%) | $20,163,596 (-67.39%) | $61,828,698 (-31.68%) |
Earnings Before Tax (EBT) | -$10,330,000 (64.43%) | -$29,041,000 (-7.35%) | -$27,052,000 (15.24%) | -$31,917,000 (38.88%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$9,815,000 (65.44%) | -$28,396,000 (-7.62%) | -$26,386,000 (15.64%) | -$31,278,000 (39.46%) |
Invested Capital | -$1,731,000 (38.40%) | -$2,810,000 (-395.79%) | $950,000 (-41.14%) | $1,614,000 (151.65%) |
Working Capital | -$1,920,000 (52.64%) | -$4,054,000 (-90.06%) | -$2,133,000 (-118.85%) | $11,318,000 (-53.29%) |
Tangible Asset Value | $573,000 (-62.05%) | $1,510,000 (-60.29%) | $3,803,000 (-74.97%) | $15,193,000 (-49.42%) |
Market Capitalization | $25,680,044 (-38.64%) | $41,851,093 (107.51%) | $20,168,596 (-74.39%) | $78,742,698 (-33.25%) |
Average Equity | -$1,569,000 (-220.20%) | -$490,000 (-110.66%) | $4,596,500 (-71.45%) | $16,099,250 (-36.48%) |
Average Assets | $1,739,000 (-51.01%) | $3,549,750 (-54.57%) | $7,814,250 (-60.80%) | $19,933,750 (-35.17%) |
Invested Capital Average | -$2,050,750 (-217.95%) | -$645,000 (-133.57%) | $1,921,250 (1352.74%) | $132,250 (-88.24%) |
Shares | 17,234,929 (95.61%) | 8,810,756 (83.48%) | 4,802,047 (35.99%) | 3,531,063 (16.73%) |